♫musicjinni

Experimental Alzheimer's drug may slow progression, but with significant side effects, study shows

video thumbnail
A new study finds that an experimental Alzheimer's drug may slow the progression of the disease in its early stages, but it comes with significant side effects. CBS News chief medical correspondent Dr. Jon LaPook joins John Dickerson on "Prime Time" to discuss.

#news #alzheimers #health

CBS News Streaming Network is the premier 24/7 anchored streaming news service from CBS News and Stations, available free to everyone with access to the Internet. The CBS News Streaming Network is your destination for breaking news, live events and original reporting locally, nationally and around the globe. Launched in November 2014 as CBSN, the CBS News Streaming Network is available live in 91 countries and on 30 digital platforms and apps, as well as on CBSNews.com and Paramount+.

Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews
Watch CBS News: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: http://facebook.com/cbsnews
Follow CBS News on Twitter: http://twitter.com/cbsnews
Subscribe to our newsletters: http://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: licensing@veritone.com

Experimental Alzheimer's drug may slow progression, but with significant side effects, study shows

Brain scan may help diagnose Alzheimer's

How new Alzheimer's drug Leqembi works, risks and who might benefit

Neurosurgeon pioneers Alzheimer's, addiction treatments using ultrasound | 60 Minutes

Experimental Alzheimer's drug shows promise

Alzheimer's and Dementia | 60 Minutes Full Episodes

New Blood Test May Help Detect Alzheimer's Disease Early

Experimental treatment for Alzheimer's prevention

The hope for early detection of Alzheimer's disease

Alzheimer's: Lower your risk by eating right

Alzheimer's expert shares healthy brain advice

MRI could be used to identify risk for dementia

New Alzheimers med approved? But is it worth the cost?

Disclaimer DMCA